Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 (Q61646585)
Jump to navigation
Jump to search
scientific article published on 01 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 |
scientific article published on 01 January 2007 |
Statements
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 (English)
Dinesh Khanna
Nancy Silliman
James Streisand
John Powell
John Coppock
Frank van den Hoogen
Joanna Haas
Stephen Ledbetter
Christopher P Denton
Peter A Merkel
Daniel E Furst
Vivien M Hsu
Anita Akesson
Maureen D Mayes
Joseph H Korn
Carol M Black
James R Seibold
Cat-192 Study Group
Scleroderma Clinical Trials Consortium
1 January 2007